In Florida, medical cannabis patients purchased over $162 million worth of product in March, bringing the state’s 2025 total to around $450 million.
According to data released today by the research firm Headset, Florida’s medical cannabis industry generated $162,994,063 in total sales in March, a slight decrease from the $172 million sold in March. The drop is attributed to a notable decrease in average prices.
Dried marijuana flower once again dominated the market in March, accounting for the largest share of purchases at around 44%. That was followed by vapor pens, edibles, concentrates, pre-rolls, capsules, and tinctures/topicals, maintaining similar sales patterns seen in prior months.
As of April 2, Florida has 905,556 registered medical marijuana patients, according to the Florida Department of Health. That’s an increase of more than 4,000 since the end of January, underscoring the continued growth of the state’s program.
Florida’s medical marijuana system was established following the passage of Amendment 2 in 2016, allowing patients with a range of qualifying conditions to access marijuana products through licensed dispensaries with a physician’s recommendation.
While March’s total fell short of the state’s all-time record set in March 2024 ($172 million), it continues a strong year as the state inches closer to a potential expansion into recreational sales. A legalization initiative backed by Smart & Safe Florida has been submitted for the 2026 ballot, and recent polling shows 67% of voters support the change.
